| Cardiac Disease in Childhood Cancer Survivors: Risk Prediction, Prevention, and Surveillance: JACC CardioOncology State-of-the-Art Review JM Leerink, EC de Baat, EAM Feijen, L Bellersen, EC van Dalen, ... Cardio Oncology 2 (3), 363-378, 2020 | 87 | 2020 |
| Systematic review and updated recommendations for cardiomyopathy surveillance for survivors of childhood, adolescent, and young adult cancer from the International Late Effects … MJ Ehrhardt, JM Leerink, RL Mulder, A Mavinkurve-Groothuis, W Kok, ... The Lancet Oncology 24 (3), e108-e120, 2023 | 67 | 2023 |
| Primary cardioprotection with dexrazoxane in patients with childhood cancer who are expected to receive anthracyclines: recommendations from the International Late Effects of … EC de Baat, EC van Dalen, RL Mulder, MM Hudson, MJ Ehrhardt, ... The Lancet Child & Adolescent Health 6 (12), 885-894, 2022 | 37 | 2022 |
| Refining the 10-year prediction of left ventricular systolic dysfunction in long-term survivors of childhood cancer JM Leerink, HJH van der Pal, LCM Kremer, EAM Feijen, PG Meregalli, ... Cardio Oncology 3 (1), 62-72, 2021 | 37 | 2021 |
| Aortic diameter growth in children with a bicuspid aortic valve R Merkx, AL Duijnhouwer, E Vink, JW Roos-Hesselink, M Schokking The American journal of cardiology 120 (1), 131-136, 2017 | 33 | 2017 |
| Asymptomatic systolic dysfunction on contemporary echocardiography in anthracycline-treated long-term childhood cancer survivors: a systematic review R Merkx, JM Leerink, EC de Baat, EAM Feijen, WEM Kok, ... Journal of Cancer Survivorship, 1-15, 2022 | 18 | 2022 |
| Echocardiography protocol for early detection of cardiac dysfunction in childhood cancer survivors in the multicenter DCCSS LATER 2 CARD study: design, feasibility, and … R Merkx, JM Leerink, ELAM Feijen, LCM Kremer, EC de Baat, L Bellersen, ... Echocardiography 38 (6), 951-963, 2021 | 18 | 2021 |
| Differences in aortopathy in patients with a bicuspid aortic valve with or without aortic coarctation A Duijnhouwer, A van den Hoven, R Merkx, M Schokking, ... Journal of Clinical Medicine 9 (2), 290, 2020 | 15 | 2020 |
| Extensive cardiac function analyses using contemporary echocardiography in childhood cancer survivors: a DCCSS LATER study R Merkx, JM Leerink, ELAM Feijen, EC de Baat, L Bellersen, D Bresters, ... Cardio Oncology 5 (4), 472-485, 2023 | 12 | 2023 |
| Cardiac abnormalities in girls with Turner syndrome: ECG abnormalities, myocardial strain imaging, and karyotype–phenotype associations ID Noordman, Z Fejzic, M Bos, AL Duijnhouwer, G Weijers, M Kempers, ... American Journal of Medical Genetics Part A 185 (8), 2399-2408, 2021 | 11 | 2021 |
| Cardiac function in childhood cancer survivors treated with vincristine: echocardiographic results from the DCCSS LATER 2 CARD study R Merkx, ELAM Feijen, JM Leerink, EC de Baat, L Bellersen, ... International journal of cardiology 369, 69-76, 2022 | 6 | 2022 |
| Cardiac events in childhood cancer survivors treated with anthracyclines: the value of previous myocardial strain measurement M Pourier, R Merkx, J Loonen, A van Cleef, C de Korte, L Bellersen, ... Life 12 (3), 452, 2022 | 6 | 2022 |
| Candidate Plasma Biomarkers to Detect Anthracycline‐Related Cardiomyopathy in Childhood Cancer Survivors: A Case Control Study in the Dutch Childhood Cancer Survivor Study JM Leerink, EAM Feijen, PD Moerland, EC De Baat, R Merkx, ... Journal of the American Heart Association 11 (14), e025935, 2022 | 5 | 2022 |
| A biomarker-based diagnostic model for cardiac dysfunction in childhood cancer survivors JM Leerink, EAM Feijen, EC de Baat, R Merkx, HJH van der Pal, ... Cardio Oncology 6 (2), 236-247, 2024 | 4 | 2024 |
| Presence and utility of electrocardiographic abnormalities in long-term childhood cancer survivors EC de Baat, R Merkx, JM Leerink, C Boerhout, HJH van der Pal, ... Heart 110 (10), 726-734, 2024 | | 2024 |
| PRIMARY CARDIOPROTECTION WITH DEXRAZOXANE IN CHILDHOOD CANCER PATIENTS EXPECTED TO RECEIVE ANTHRACYCLINES: RECOMMENDATIONS FROM THE INTERNATIONAL LATE EFFECTS OF CHILDHOOD … E Van Dalen, E De Baat, R Mulder, M Hudson, M Ehrhardt, F Engels, ... PEDIATRIC BLOOD & CANCER 69, 2022 | | 2022 |
| SYSTOLIC DYSFUNCTION IN CHILDHOOD CANCER SURVIVORS ON ECHOCARDIOGRAPHY: SEX-SPECIFIC EFFECTS AND RISK BEYOND CARDIOTOXIC EXPOSURES. RESULTS FROM THE DCCSS LATER 2 CARD STUDY R Merkx, J Leerink, EL Feijen, E De Baat, L Bellersen, E Van Dalen, ... PEDIATRIC BLOOD & CANCER 69, S495-S495, 2022 | | 2022 |
| Echocardiography for the 10-year prediction of cardiomyopathy in long-term survivors of childhood cancer JM Leerink, HJH Van Der Pal, EAM Feijen, PG Meregalli, MS Pourier, ... European Heart Journal 41 (Supplement_2), ehaa946. 3254, 2020 | | 2020 |
| Aortic Diameter Growth in Children with a Bicuspid Aortic Valve (vol 120, pg 131, 2017) R Merkx, AL Duijnhouwer, E Vink, JW Roos-Hesselink, M Schokking AMERICAN JOURNAL OF CARDIOLOGY 122 (3), 526-526, 2018 | | 2018 |
| ELECTROCARDIOGRAPHIC ABNORMALITIES IN CHILDHOOD CANCER SURVIVORS: A DCCSS LATER 2 CARD STUDY EC de Baat, R Merkx, JM Leerink, C Boerhout, HJH van der Pal, ... Cardiotoxicity in childhood cancer survivors: risk of low dose cancer …, 0 | | |
Jan M LeerinkAmsterdam UMC, University of Amsterdam; Princess Maxima Center, UtrechtVerified email at amsterdamumc.nl